Kim McFann
Impact in
-
- Complementary and Alternative Medicine Studies
- Nephrology top 0.5%
- Gout, Hyperuricemia, Uric Acid
Papers in
- Nephrology 31
- Gout, Hyperuricemia, Uric Acid 11
- Renal Diseases and Glomerulopathies 10
-
- Diabetes Management and Research 29
- Diabetes Treatment and Management 14
- Co-authors
- Patricia M. BarnesRichard L. NahinEve Powell‐GrinerRobert W. SchrierMarc MossMichel ChoncholDiana JalalMeredith Mealer
- Journals
- The Journal of Pediatrics (10 papers)Diabetes Care (7 papers)Clinical Journal of the American Society of Nephrology (7 papers)Pediatric Diabetes (6 papers)Diabetes Technology & Therapeutics (5 papers)
- Partner nations
- United StatesTürkiyeItaly
In The Last Decade
Kim McFann
120 papers receiving 7.3k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Complementary and alternative medicine 1.3k
- Nephrology 1.1k
- Endocrinology, Diabetes and Metabolism 1.5k
- Geriatrics and Gerontology 303
- Genetics 1.8k
Countries citing papers authored by Kim McFann
This map shows the geographic impact of Kim McFann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim McFann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim McFann more than expected).
Fields of papers citing papers by Kim McFann
This network shows the impact of papers produced by Kim McFann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim McFann. The network helps show where Kim McFann may publish in the future.
Co-authors
The 25 scholars most cited alongside Kim McFann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2015 | 14 | |
| 3 | 2014 | 79 | |
| 4 | 2014 | 4 | |
| 5 | 2014 | 37 | |
| 6 | 2013 | 81 | |
| 7 | 2012 | 36 | |
| 8 | 2011 | 27 | |
| 9 | 2011 | 32 | |
| 10 | 2011 | 19 | |
| 11 | 2010 | 16 | |
| 12 | 2010 | 8 | |
| 13 | 2010 | 147 | |
| 14 | 2010 | 42 | |
| 15 | 2010 | 170 | |
| 16 | 2010 | 67 | |
| 17 | 2006 | 46 | |
| 18 | 2006 | 97 | |
| 19 | 2006 | 28 | |
| 20 | 2003 | 44 |
About Kim McFann
Kim McFann is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism, Genetics, Critical Care and Intensive Care Medicine and Complementary and Manual Therapy, having authored 121 papers that have together received 7.6k indexed citations. Recurring topics across this work include Diabetes Management and Research (29 papers), Diabetes and associated disorders (21 papers), Pancreatic function and diabetes (18 papers), Genetic and Kidney Cyst Diseases (17 papers), Diabetes Treatment and Management (14 papers), Gout, Hyperuricemia, Uric Acid (11 papers), Renal Diseases and Glomerulopathies (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). The work is most often cited by research in Complementary and alternative medicine (1.3k citations), Nephrology (1.1k citations), Endocrinology, Diabetes and Metabolism (1.5k citations), Geriatrics and Gerontology (303 citations) and Genetics (1.8k citations). Kim McFann has collaborated with scholars based in United States, Türkiye and Italy. Frequent co-authors include Patricia M. Barnes, Richard L. Nahin, Eve Powell‐Griner, Robert W. Schrier, Marc Moss, Michel Chonchol, Diana Jalal, Meredith Mealer, Marc Moss and H. Peter Chase. Their work appears in journals such as The Journal of Pediatrics, Diabetes Care, Clinical Journal of the American Society of Nephrology, Pediatric Diabetes and Diabetes Technology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.